Ping Li is currently a Global Study Director at AstraZeneca, bringing over five years of clinical research experience focused on phase I-IV trials, particularly in Oncology, Hematology, and Cellular Therapies. Previously, Ping served in various roles, including Sr. Data & Regulatory Coordinator and Clinical Research Coordinator, where they excelled in managing clinical trials, ensuring compliance, and enhancing organizational efficiency through innovative data management solutions. Ping holds a Bachelor of Applied Science in Nutrition Sciences and a certification in Data Analytics from Ryerson University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices